Hilary L Surratt1, Janet K Otachi1, Timothy Williams1, Jennifer Gulley2, A Scott Lockard3, Rebecca Rains4. 1. Center for Health Services Research, College of Medicine, University of Kentucky, Lexington, Kentucky. 2. Clark County Health Department, Winchester, Kentucky. 3. Kentucky River District Health Department, Hazard, Kentucky. 4. Knox County Health Department, Barbourville, Kentucky.
Abstract
PURPOSE: Kentucky experiences a disproportionate burden of substance use disorder (SUD), particularly in rural areas of the state. Multiple factors increase vulnerability to SUD and limit access to services in rural communities. However, the recent implementation and expansion of syringe service programs (SSPs) in rural Kentucky may provide a leverage point to reach at-risk people who inject drugs (PWID). METHODS: Data were collected as part of an ongoing NIDA-funded study designed to examine uptake of SSPs among PWID in Appalachian Kentucky. Using Respondent Driven Sampling (RDS), the study enrolled a sample of 186 PWID SSP attenders across 3 rural Appalachian Kentucky counties and conducted face-to-face interviews regarding health behaviors, injecting practices, SSP utilization, and treatment services. Using logistic regression analyses, we examined consistent SSP use, as well as importance and confidence to reduce substance use as predictors of current treatment participation. FINDINGS: For the prior 6 months, 44.6% of the sample reported consistent SSP use. Consistent use of SSPs was associated with treatment participation in the unadjusted logistic regression models. Significant predictors of treatment participation in the adjusted model included high confidence to reduce substance use, and not reporting primary methamphetamine injection. CONCLUSIONS: Rurally located SSPs may play an important role in supporting confidence and motivation to change substance use behaviors among PWID impacted by SUD. SSPs may be critical venues for integration and expansion of prevention, health promotion, and treatment linkage services for this underserved population.
PURPOSE: Kentucky experiences a disproportionate burden of substance use disorder (SUD), particularly in rural areas of the state. Multiple factors increase vulnerability to SUD and limit access to services in rural communities. However, the recent implementation and expansion of syringe service programs (SSPs) in rural Kentucky may provide a leverage point to reach at-risk people who inject drugs (PWID). METHODS: Data were collected as part of an ongoing NIDA-funded study designed to examine uptake of SSPs among PWID in Appalachian Kentucky. Using Respondent Driven Sampling (RDS), the study enrolled a sample of 186 PWID SSP attenders across 3 rural Appalachian Kentucky counties and conducted face-to-face interviews regarding health behaviors, injecting practices, SSP utilization, and treatment services. Using logistic regression analyses, we examined consistent SSP use, as well as importance and confidence to reduce substance use as predictors of current treatment participation. FINDINGS: For the prior 6 months, 44.6% of the sample reported consistent SSP use. Consistent use of SSPs was associated with treatment participation in the unadjusted logistic regression models. Significant predictors of treatment participation in the adjusted model included high confidence to reduce substance use, and not reporting primary methamphetamine injection. CONCLUSIONS: Rurally located SSPs may play an important role in supporting confidence and motivation to change substance use behaviors among PWID impacted by SUD. SSPs may be critical venues for integration and expansion of prevention, health promotion, and treatment linkage services for this underserved population.
Authors: Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea Journal: Am J Public Health Date: 2013-12-12 Impact factor: 9.308
Authors: Svetla Slavova; Julia F Costich; Terry L Bunn; Huong Luu; Michael Singleton; Sarah L Hargrove; Jeremy S Triplett; Dana Quesinberry; William Ralston; Van Ingram Journal: Int J Drug Policy Date: 2017-07-18
Authors: André Moser; Andreas E Stuck; Rebecca A Silliman; Patricia A Ganz; Kerri M Clough-Gorr Journal: J Clin Epidemiol Date: 2012-07-20 Impact factor: 6.437
Authors: Hilary L Surratt; Hannah J Yeager; Akosua Adu; Evelyn A González; Elizabeth O Nelson; Tamara Walker Journal: Front Psychiatry Date: 2022-05-30 Impact factor: 5.435